Clinical Trial Update: Psilocybin With Psychotherapy for Improving Chronic Pain in Cancer Patients Requiring Opioids [Phase 2]

View source ↗

Summary

Phase 2 study of psilocybin with psychotherapy to improve chronic pain in cancer patients requiring opioids; the trial is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancy
• Solid Malignant Tumor

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm | Phase 2 | Status: NOT_YET_RECRUITING